Slideshow
Author(s):
A new study has found that patients with neuropsychiatric systemic lupus erythematosus have 3 times increased risk of death, and this risk increases to over 7 times higher in patients with focal CNS symptoms.
Study Identifies Key Inflammatory Markers in Pediatric MOGAD, Suggesting New Therapeutic Targets
Episode 134: Previewing the 2025 ACTRIMS Forum
Breaking Down ISC 2025: Key Takeaways From Experts in Stroke Neurology
Episode 133: Clinical Guidance on Neuromodulation for Lennox-Gastaut Syndrome
Dubai Study Highlights Disease Characteristics and Treatment Outcomes in NMOSD and MOGAD
FDA Approves Tablet Formulation of Risdiplam for Spinal Muscular Atrophy